Peptide-based multimeric targeted contrast agents

Details for Australian Patent Application No. 2002318931 (hide)

Owner Epix Pharmaceuticals, Inc.

Inventors Koerner, Steffi K.; Caravan, Peter D.; Amedio, John C.; McMurry, Thomas J.; Dumas, Stephane; Wang, Xifang; Nivorozhkin, Alexander L.; Kolodziej, Andrew; Zhang, Zhaoda; Sun, Wei-Chuan; Nair, Shrikumar

Agent Cullen & Co

Pub. Number AU-B-2002318931

PCT Number PCT/US02/24261

PCT Pub. Number WO2003/011115

Priority 60/308,721 30.07.01 US

Filing date 30 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 17 January 2008

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 49/00 (2006.01) Preparations for testing

A61K 49/08 (2006.01) Preparations for testing

C07K 5/117 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/308,721 30.07.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002318931

10 November 2005 Change of Name(s) of Applicant(s), Section 104

  Epix Medical, Inc. The name of the applicant has been changed to Epix Pharmaceuticals, Inc.

17 January 2008 Application Accepted

  Published as AU-B-2002318931

15 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318932-SHIPPING SHARED SERVICESPOSTAGE INDICIA

2002318930-Null-pilot symbol assisted fast automatic frequency control